Stay Informed
Medical Links
- 2010 Alzheimer's Disease Facts and Figures - updated facts for 2010 on AD
- Abbott Laboratories
- Adult Care Advisors
- Alcoeur Gardens - Special care for the Alzheimer’s Disease patient
- Alzheimer’s Disease information provided by Novartis Pharmaceuticals - For patients and caregivers
- Alzheimer’s Foundation of America
- Alzheimer’s Foundation of America - Support resource for patients, cargivers and health care professionals
- Alzheimer’s Disease Clinical Trials
- Bristol-Myers Squibb Prodromal AD study
- CLINICAL RESEARCH TRIALS IN ALZHEIMER'S DISEASE - All current AD trials in the United States
- Clinical Trials at Memory Enhancement Centers of America - Clinical Research Trials
- COVANCE
- Dr Danov : Neuropsychologist PC - Pediatric and Adult Neuropsychology
- Eisai
- Elan Corporation
- Geriatric Medical Center of Dr. Sanjiv, Sharma, MD - First class geriatric medical care for seniors
- ICON Central Laboratories
- Lori Wright Consulting - CNS research consulting firm
- Neuronascent
- Novartis
- Pfizer
- Quintiles
- Sanofi-Aventis
- The Regency at Dover (Toms River, NJ) - “A Premier Senior Club”
- Wyeth Pharmaceuticals
Links
Search
 |
Joel S. Ross, MD |
MD FACP AGSF CMD CPI |
President and Founder |
Memory Enhancement Center |
of America, Inc. |
4 Industrial Way West, 2nd Floor |
Eatontown, New Jersey 07724 |
732.571.1535 |
« New Approaches to Alzheimer’s Disease Treatments | Home | Can Alzheimer’s Disease Be Prevented? »
Iberica USA opens its new State of Art Phase I/IIA Facility
By Joel Ross | January 17, 2008
Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica’s Clinical Research Center (ICRC) will bring a new level of high quality phase I/IIA research to the pharmaceutical world.
It “home like” environment, 20 single rooms and 4 double bedded rooms, staffed with the most caring and qualified personnel will provide outstanding care to healthy volunteers in phase I studies as well as to provide a perfect environment for Japanese Bridging studies.
Dr. Ross’s Memory Enhancement Center of America (MECA) will also be conducting clinical trials for Alzheimer’s Disease in the safest and most comfortable settings possible within ICRC
The MECA will provide pharmaceutical sponsors with the availability of continuous spinal fluid analysis in Alzheimer’s Disease subjects as well as in healthy volunteers to assess the penetration of new compounds through the blood brain barrier, so critically important in the ever growing field of new compounds combating the devastating disease of Alzheimer’s.
Dr. Joel Ross discusses the opening of the new Iberica USA facility in Eatontown, New Jersey with WOBM-AM’s Bob and Marianne during a radio show interview.
Dr. Ross radio interview - on WOBM-AM - Bob and Marianne [12:07m]: Play Now | Play in Popup | DownloadTopics: Clinical Research Study, Clinical Trials | No Comments »